Parkinson's Disease (PD) is a neurodegenerative disease characterized by loss of the dopamine-containing neurons in the substantia nigra pars conpacta (SNpc). Although the cause of neuronal death remains unclear, increasing evidence points to the role of chronic inflammatory processes. In order to explore the possibility that microglial activation causes dopaminergic cell death, we injected lipopolysaccharide (LPS) into the SNpc. The LPS injection not only induced microglial activation, but also resulted in a dose-dependent, selective loss of dopaminergic neurons by apoptosis in the SNpc. We therfore hypothesize that an environmental toxin, such as LPS may activate microglia in the substantia nigra (SN), resulting in the release of cytotoxic agents. These agents may, in turn, activate signal transduction pathways that may cause neuronal degeneration of the dopaminergic neurons in the SN. To test this hypothesis, we propose the following specific aims: 1) To determine if the dopaminergic neurons of the SN are specifically susceptible to inflammatory processes, we swill inject LPS into three discrete brain areas, SN, striatum and hippocampus. Activation of microglia will be characterized by morphological changes and measured by OX-42 immunostaining. Survival of dopaminergic neurons as well as other neuronal populations, such as GABAergic and serotonergic neurons, in the SN will be determined by immunocytochemistry. Neuronal survival in other area of the brain will be examined using specific neuronal markers. 2) To elucidate the molecular mechanisms underlying neuronal degeneration induced by LPS, we will measure the activation of three signal transduction factors, NPkB, P38 MAP kinase, and c-jun N-terminal kinase. In addition, the expression of inflammatory cytokines and apoptosis-related genes will be determined by RNase protection assay. 3) To protect dopaminergic neurons from LPS toxicity, we will inject IL-4, a cytokine that inhibits microglial activation, the microphage inhibitory factor, or the opiate antagonist naloxone. The long-term goal of this study is to validate LPS treatment as a new animal model of PD that can be used to elucidate the etiology and molecular mechanisms underlying PD and to develop novel therapeutic treatments for this and other neurodegenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS039345-01S2
Application #
6292075
Study Section
Special Emphasis Panel (ZRG1 (01))
Program Officer
Murphy, Diane
Project Start
1999-09-30
Project End
2000-06-30
Budget Start
1999-09-30
Budget End
2000-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$3,432
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Choi, Dong-Young; Liu, Mei; Hunter, Randy L et al. (2009) Striatal neuroinflammation promotes Parkinsonism in rats. PLoS One 4:e5482
Bing, Guoying; Nguyen, Xuan V; Liu, Mei et al. (2006) Biophysical and biochemical characterization of the intrinsic fluorescence from neurofibrillary tangles. Neurobiol Aging 27:823-30
Liu, Mei; Sun, Anyang; Shin, Eun-Joo et al. (2006) Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin. Eur J Neurosci 23:2027-34
Zhang, J; Stanton, D M; Nguyen, X V et al. (2005) Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits. Neuroscience 135:829-38
Sun, Anyang; Liu, Mei; Nguyen, Xuan V et al. (2003) P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp Neurol 183:394-405
Arimoto, Toyoko; Bing, Guoying (2003) Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol Dis 12:35-45
Sun, Anyang; Nguyen, Xuan V; Bing, Guoying (2002) Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J Histochem Cytochem 50:463-72
Sun, Anyang; Koelsch, Gerald; Tang, Jordan et al. (2002) Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls. Exp Neurol 175:10-22
Sun, A; Nguyen, X V; Bing, G (2001) A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease. J Neurosci Methods 111:17-27